NO20031740L - Anvendelse av antiprogestiner for profylakse og behandling av hormonavhengige sykdommer - Google Patents

Anvendelse av antiprogestiner for profylakse og behandling av hormonavhengige sykdommer

Info

Publication number
NO20031740L
NO20031740L NO20031740A NO20031740A NO20031740L NO 20031740 L NO20031740 L NO 20031740L NO 20031740 A NO20031740 A NO 20031740A NO 20031740 A NO20031740 A NO 20031740A NO 20031740 L NO20031740 L NO 20031740L
Authority
NO
Norway
Prior art keywords
antiprogestins
hormone
prophylaxis
treatment
dependent diseases
Prior art date
Application number
NO20031740A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031740D0 (no
Inventor
Jens Hoffmann
Rosemarie Lichtner
Gerhard Siemeister
Martin Schneider
Ulrike Fuhrmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20031740D0 publication Critical patent/NO20031740D0/no
Publication of NO20031740L publication Critical patent/NO20031740L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20031740A 2000-10-18 2003-04-15 Anvendelse av antiprogestiner for profylakse og behandling av hormonavhengige sykdommer NO20031740L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24099800P 2000-10-18 2000-10-18
EP00250341 2000-10-18
PCT/EP2001/012005 WO2002032430A1 (en) 2000-10-18 2001-10-17 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases

Publications (2)

Publication Number Publication Date
NO20031740D0 NO20031740D0 (no) 2003-04-15
NO20031740L true NO20031740L (no) 2003-06-17

Family

ID=26072951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031740A NO20031740L (no) 2000-10-18 2003-04-15 Anvendelse av antiprogestiner for profylakse og behandling av hormonavhengige sykdommer

Country Status (26)

Country Link
US (1) US7378406B2 (xx)
EP (1) EP1328276B1 (xx)
JP (2) JP2004511522A (xx)
KR (1) KR100632908B1 (xx)
CN (1) CN1512886A (xx)
AT (1) ATE310522T1 (xx)
AU (2) AU1824302A (xx)
BG (1) BG107743A (xx)
BR (1) BR0114665A (xx)
CA (1) CA2423017C (xx)
CY (1) CY1104981T1 (xx)
CZ (1) CZ299942B6 (xx)
DE (1) DE60115274T2 (xx)
DK (1) DK1328276T3 (xx)
EE (1) EE05259B1 (xx)
ES (1) ES2253443T3 (xx)
HR (1) HRP20030387A2 (xx)
HU (1) HUP0301460A3 (xx)
IL (2) IL154975A0 (xx)
MX (1) MXPA03002954A (xx)
NO (1) NO20031740L (xx)
NZ (1) NZ538346A (xx)
PL (1) PL360151A1 (xx)
SI (1) SI1328276T1 (xx)
SK (1) SK287124B6 (xx)
WO (1) WO2002032430A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27301A1 (es) * 2001-05-25 2003-02-28 Schering Ag Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
US9517240B2 (en) * 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
EP2136796A2 (en) * 2007-04-23 2009-12-30 Bayer Schering Pharma Aktiengesellschaft Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen
US20080268041A1 (en) * 2007-04-23 2008-10-30 Jens Hoffmann Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
US20080261929A1 (en) * 2007-04-23 2008-10-23 Jens Hoffmann Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseases
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
TWI539953B (zh) * 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
CN107260746A (zh) * 2010-03-22 2017-10-20 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
EA030444B1 (ru) 2012-05-31 2018-08-31 Репрос Терапьютикс Инк. Способ лечения прогестеронзависимого состояния
ES2688821T3 (es) 2012-11-02 2018-11-07 Repros Therapeutics Inc. Métodos y composiciones para tratar afecciones dependientes de la progesterona

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

Also Published As

Publication number Publication date
SK4742003A3 (en) 2004-09-08
NZ538346A (en) 2007-03-30
US20040048841A1 (en) 2004-03-11
SK287124B6 (sk) 2009-12-07
EE05259B1 (et) 2010-02-15
EP1328276A1 (en) 2003-07-23
JP2004511522A (ja) 2004-04-15
EE200300155A (et) 2003-08-15
ATE310522T1 (de) 2005-12-15
IL154975A (en) 2007-05-15
WO2002032430A1 (en) 2002-04-25
KR100632908B1 (ko) 2006-10-13
KR20030044007A (ko) 2003-06-02
CY1104981T1 (el) 2010-03-03
DE60115274T2 (de) 2006-07-27
BR0114665A (pt) 2004-01-13
HUP0301460A3 (en) 2010-01-28
CN1512886A (zh) 2004-07-14
IL154975A0 (en) 2003-10-31
CA2423017C (en) 2009-01-06
NO20031740D0 (no) 2003-04-15
MXPA03002954A (es) 2003-08-07
SI1328276T1 (sl) 2006-04-30
CZ299942B6 (cs) 2008-12-29
DK1328276T3 (da) 2006-04-03
HUP0301460A2 (hu) 2003-10-28
AU2002218243B2 (en) 2006-07-13
HRP20030387A2 (en) 2005-04-30
PL360151A1 (en) 2004-09-06
AU1824302A (en) 2002-04-29
CA2423017A1 (en) 2002-04-25
DE60115274D1 (de) 2005-12-29
JP2010077158A (ja) 2010-04-08
ES2253443T3 (es) 2006-06-01
BG107743A (bg) 2004-01-30
US7378406B2 (en) 2008-05-27
EP1328276B1 (en) 2005-11-23

Similar Documents

Publication Publication Date Title
NO20031740D0 (no) Anvendelse av antiprogestiner for profylakse og behandling av hormonavhengige sykdommer
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
KR970704451A (ko) 기능부전성 자궁출혈 치료용 약제의 제조에 유용한 프로게스테론 길항제(Progesterone Antagonists Useful for Preparing Medicaments for Treating Dysfunctional Uterine Bleeding)
MXPA05012841A (es) Composicion que comprende antagonistas de receptores de progesterona y antiestrogenos puros para la profilaxis y el tratamiento de enfermedades dependientes de hormonas.
EE200300157A (et) Antiprogestiinide kasutamine apoptoosi esilekutsumiseks rakus
YU30103A (sh) Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti
TW200733955A (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
RS50350B (sr) Upotreba 11beta-(4-acetilfenil)-17beta-hidroksi-17alfa-(1,1,2,2,2-pentafluoretil)estra-4,9-dien-3-ona za pripremanje medikamenta za lečenje kancera dojke, jajnika, endometrijuma, mijeloma i meningioma
TH58099B (th) การใช้ และสารผสมแอนติโปรเจสตินในการรักษาโรคต่อมลูกหมาก
UY27301A1 (es) Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application